Patent · US Active

Signal confinement sequencing (SCS) and nucleotide analogues for signal confinement sequencing

US10190162B2 · kind B2 · utility

1Cited by
37References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2015
Grant dateJan 29, 2019
Priority date
Expiry dateSep 12, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6869
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel fluorescent nucleotide analogs are provided herein. Also provided herein are methods of using the nucleotide analogs in sequencing-by-synthesis and signal confinement methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.